- Home
- NGD vs JANX Comparison
NGD vs JANX Comparison
Compare NGD & JANX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NGD
- JANX
- Stock Information
- Founded
- NGD N/A
- JANX 2017
- Country
- NGD Canada
- JANX United States
- Employees
- NGD N/A
- JANX N/A
- Industry
- NGD
- JANX Biotechnology: Pharmaceutical Preparations
- Sector
- NGD
- JANX Health Care
- Exchange
- NGD Nasdaq
- JANX Nasdaq
- Market Cap
- NGD 2.4B
- JANX 2.2B
- IPO Year
- NGD 2004
- JANX 2021
- Fundamental
- Price
- NGD $2.83
- JANX $36.01
- Analyst Decision
- NGD Buy
- JANX Strong Buy
- Analyst Count
- NGD 4
- JANX 11
- Target Price
- NGD $3.23
- JANX $83.09
- AVG Volume (30 Days)
- NGD 14.5M
- JANX 821.6K
- Earning Date
- NGD 02-19-2025
- JANX 03-07-2025
- Dividend Yield
- NGD N/A
- JANX N/A
- EPS Growth
- NGD N/A
- JANX N/A
- EPS
- NGD 0.02
- JANX N/A
- Revenue
- NGD $861,500,000.00
- JANX $13,049,000.00
- Revenue This Year
- NGD $19.21
- JANX $39.66
- Revenue Next Year
- NGD $28.63
- JANX N/A
- P/E Ratio
- NGD $119.51
- JANX N/A
- Revenue Growth
- NGD 14.85
- JANX 54.12
- 52 Week Low
- NGD $1.10
- JANX $14.68
- 52 Week High
- NGD $3.25
- JANX $71.71
- Technical
- Relative Strength Index (RSI)
- NGD 46.34
- JANX 34.78
- Support Level
- NGD $2.75
- JANX $36.13
- Resistance Level
- NGD $3.07
- JANX $38.13
- Average True Range (ATR)
- NGD 0.15
- JANX 2.52
- MACD
- NGD -0.03
- JANX 0.08
- Stochastic Oscillator
- NGD 18.75
- JANX 5.71
About NGD New Gold Inc.
New Gold Inc participates in the development and operation of intermediate mining properties. The company has a portfolio of two primary assets: the Rainy River Mine and the New Afton Mine in Canada. The company also owns the Cerro San Pedro Mine in Mexico. The company derives revenue from the sale of gold, copper, and silver.
About JANX Janux Therapeutics Inc.
Janux Therapeutics Inc is a clinical-stage biopharmaceutical company developing next-generation therapeutics based on proprietary tumor activated T Cell Engager platform technology to treat patients suffering from cancer.